STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($) $ in Thousands		1 Months Ended	12 Months Ended
	Feb. 10, 2021	Aug. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from exercise of warrants				$ 707
Number of shares exercised
Preferred stock, authorized			5,000,000	5,000,000
Treasury stock, shares			17,477	17,477
Treasury stock at cost			$ 40	$ 40
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, authorized			5,000,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate grant date fair value			$ 515
Stock-based compensation expense			$ 515
Common Stock [Member] | Underwritten Public Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued in transaction	750,000
Offering net proceeds	$ 12,466
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant to purchase shares of common stock				225,878
Proceeds from exercise of warrants				$ 707
Number of shares exercised				120,000
Stock issued during the period, cashless exercise option				61,644
Officers Employees and Consultants [Member] | Employee Retention Program [Member] | 2016 Omnibus Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued		161,347